Se încarcă compania
Just reported
Q3 2026 results
From Chemed's results release of 27 octombrie 2026; its quarterly report has since been filed.
Revenue
Actual
690,9M USD
+11 % y/y
+2,6 % q/qGuided
—
No guide given
EPS, GAAP
Actual
5,45 USD
+22 % y/y
+6,2 % q/qGuided
—
No guide given
Operating income, GAAP
Actual
96,4M USD
+29 % y/y
+8,1 % q/qGuided
—
No guide given
Set against the company's own guidance and the same quarter a year earlier, not analysts' estimates, which we do not hold. Adjusted figures are the company's own non-GAAP measures, as stated in the release.
The full earnings report →Keep exploring
The themes Chemed is part of, the highest-graded companies in its industry, and the companies in its sector whose grade rose recently.
The theme it is part of
Highest-graded in Medical Care Facilities
Graded A or B and worth $2B or more: A first, then the largest.
THCTenet Healthcare Corp.23,3B USDA+
EHCEncompass Health Corporation14B USDA+
ENSGEnsign Group, Inc.10,9B USDA
PACSPACS Group, Inc.7,9B USDA
CONConcentra Group Holdings Parent, Inc.5,5B USDA
Grade rose recently in Healthcare
Rose to A or B on a filing in the last 90 days, worth $2B or more: largest first.
DHRDanaher Corporation21 oct. 2026CBGraded C, now B
MCKMckesson Corporation4 nov. 2026BAGraded B, now A
CVSCVS Health Corp4 nov. 2026BAGraded B, now A
EWEdwards Lifesciences Corporation4 nov. 2026BAGraded B, now A
BIIBBiogen Inc.28 oct. 2026BAGraded B, now A
Situațiile financiare complete →
Construit din raportările proprii ale Chemed Corp. la Comisia pentru Valori Mobiliare și Burse a SUA (SEC). Cifrele sunt cele raportate, iar istoricul pe acțiune este recalculat la baza de acțiuni de azi. Aceasta descrie o afacere — nu este consultanță de investiții și nu este o recomandare de cumpărare sau vânzare.
